AndresCarmona-RubioMD
Cardiology • Cleveland, OHHeart Failure & Transplantation
Cleveland Clinic Foundation
Dr. Carmona-Rubio is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave J34
Cleveland, OH 44195Phone+1 216-445-5843
Education & Training
Cleveland Clinic FoundationFellowship, Advanced Heart Failure and Transplant Cardiology, 2019 - 2020
Cleveland Clinic (Florida)Fellowship, Cardiovascular Disease, 2016 - 2019
University at BuffaloChief Residency, Internal Medicine, 2015 - 2016- University at BuffaloResidency, Internal Medicine, 2013 - 2016
University of ZuliaClass of 2009
Certifications & Licensure
OH State Medical License 2017 - 2026
FL State Medical License 2016 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 5 citationsOpportunities for Earlier Diagnosis and Treatment of Cardiac Amyloidosis.Trejeeve Martyn, Andres Carmona Rubio, Jerry D Estep, Mazen Hanna
Methodist Debakey Cardiovascular Journal. 2022-01-01 - 80 citationsAssociation of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19).Neil Mehta, Ankur Kalra, Amy S Nowacki, Scott Anjewierden, Zheyi Han
JAMA Cardiology. 2020-09-01 - 17 citationsHigh-risk carotid plaques identified by CT-angiogram can predict acute myocardial infarction.Wassim Mosleh, Keenan Adib, Punnanithinont Natdanai, Andres E Carmona-Rubio, Roshan Karki
The International Journal of Cardiovascular Imaging. 2017-04-01
Journal Articles
- Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Testing Positive for Coronavirus Disease 2019 (COVID-19)Andres E Carmona-Rubio, Miriam Jacob, Gary W Procop, Mina K Chung, JAMA Cardiology
Authored Content
- Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Testing Positive for Coronavirus Disease 2019 (COVID-19)May 2020
Professional Memberships
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
